Strides Pharma NDC Tacrolimus Capsules Recall: FDA Class III

Why it was recalled

Failed Moisture Limits

Product description

NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816

Lot numbers, UPCs & expiration codes

Lot 7242728A; June 2023

Where it was sold

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0180-2021
Classification: Class III
Status: Terminated
Recall initiated: Dec 22, 2020
FDA report date: Jan 6, 2021
Quantity: 960 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Strides Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-0180-2021, exactly as published.

Show all FDA fields

City: East Brunswick
State: NJ
Status: Terminated
Country: United States
Event ID: 87027
Address: 2 Tower Center Blvd Ste 1102
Code information: Lot 7242728A; June 2023
Postal code: 08816-1100
Report date: Jan 6, 2021
Product type: Drugs
Recall number: D-0180-2021
Classification: Class III
Recalling firm: Strides Pharma Inc.
Product quantity: 960 bottles
Termination date: Jan 26, 2022
Reason for recall: Failed Moisture Limits
Voluntary / mandated: Voluntary: Firm initiated
Product description: NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816
Distribution pattern: PA
Recall initiation date: Dec 22, 2020
Initial firm notification: Letter
Center classification date: Dec 30, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0180-2021, published Jan 6, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

Strides Pharma Ndc 64380-721-06 Tacrolimus Capsules Recall

Summary